phase 2b/3 funding., page-5

Gavel, what you gotta realize is that nobody has proven any disease modification other than Pran. The very fact that they were able to demonstrate significant improvement in a few important fields is very good. It is very difficult to demonstrate a significant improvement in such a small, short trial, but they did it. That indicates a pretty strong effect as I understand it.
Sure the big drug companies will try to pick them up for a song,knowing they are short of cash. Prana management know what they have, know what everyone else dosent have, and I believe Prana have 20 year patent protection. I dont think a cheap sale is going to happen.
I am betting my money on it.

Once again, they are tipping the first real Alzheimers modifying drug to surpass Lipitors $12b annual turnover. I think that is more than Rio Tinto makes. OK it is unlikely PRAN will take it all the way to market, but even a percentage of that turnover would work for me.


All above is just my opinion.